152 related articles for article (PubMed ID: 38688632)
1. High-tailored Anal Canal Radiotherapy (HIT-ART): Outcomes of a 10-Year Single Center Clinical Experience.
Manfrida S; Fionda B; Mariani S; Luca V; Bertolini R; Barbaro B; Chiloiro G; Frascino V; Tagliaferri L; Gambacorta MA
In Vivo; 2024; 38(3):1306-1315. PubMed ID: 38688632
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.
Franco P; Mistrangelo M; Arcadipane F; Munoz F; Sciacero P; Spadi R; Migliaccio F; Angelini V; Bombaci S; Rondi N; Numico G; Ragona R; Cassoni P; Morino M; Racca P; Ricardi U
Cancer Invest; 2015 Jul; 33(6):259-66. PubMed ID: 25950188
[TBL] [Abstract][Full Text] [Related]
3. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal.
Tomasoa NB; Meulendijks D; Nijkamp J; Cats A; Dewit L
Acta Oncol; 2016 Jun; 55(6):760-6. PubMed ID: 26878244
[TBL] [Abstract][Full Text] [Related]
5. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.
Kachnic LA; Tsai HK; Coen JJ; Blaszkowsky LS; Hartshorn K; Kwak EL; Willins JD; Ryan DP; Hong TS
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):153-8. PubMed ID: 21095071
[TBL] [Abstract][Full Text] [Related]
6. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA
Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820
[TBL] [Abstract][Full Text] [Related]
7. Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity.
Belgioia L; Vagge S; Agnese D; Garelli S; Murialdo R; Fornarini G; Chiara S; Gallo F; Bacigalupo A; Corvò R
World J Gastroenterol; 2015 Oct; 21(37):10688-96. PubMed ID: 26457030
[TBL] [Abstract][Full Text] [Related]
8. Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.
Franco P; Arcadipane F; Ragona R; Mistrangelo M; Cassoni P; Rondi N; Morino M; Racca P; Ricardi U
Anticancer Res; 2016 Apr; 36(4):2027-32. PubMed ID: 27069197
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients.
De Bari B; Jumeau R; Bouchaab H; Vallet V; Matzinger O; Troussier I; Mirimanoff RO; Wagner AD; Hanhloser D; Bourhis J; Ozsahin EM
Acta Oncol; 2016 Jun; 55(6):767-73. PubMed ID: 27034083
[TBL] [Abstract][Full Text] [Related]
10. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal.
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Huart J; Pène F; Schlienger M
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1259-73. PubMed ID: 12873670
[TBL] [Abstract][Full Text] [Related]
11. IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center.
Vieillot S; Fenoglietto P; Lemanski C; Moscardo CL; Gourgou S; Dubois JB; Aillères N; Azria D
Radiat Oncol; 2012 Mar; 7():45. PubMed ID: 22445137
[TBL] [Abstract][Full Text] [Related]
12. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers.
Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E
Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606
[TBL] [Abstract][Full Text] [Related]
13. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study).
Moureau-Zabotto L; Ortholan C; Hannoun-Levi JM; Teissier E; Cowen D; Salem N; Lemanski C; Ellis S; Resbeut M
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e135-42. PubMed ID: 23195780
[TBL] [Abstract][Full Text] [Related]
14. Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRT.
Dell'Acqua V; Kobiela J; Kraja F; Leonardi MC; Surgo A; Zerella MA; Arculeo S; Fodor C; Ricotti R; Zampino MG; Ravenda S; Spinoglio G; Biffi R; Bazani A; Luraschi R; Vigorito S; Spychalski P; Orecchia R; Glynne-Jones R; Jereczek-Fossa BA
Med Oncol; 2018 Mar; 35(5):59. PubMed ID: 29594584
[TBL] [Abstract][Full Text] [Related]
15. Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.
Franco P; Arcadipane F; Ragona R; Mistrangelo M; Cassoni P; Rondi N; Morino M; Racca P; Ricardi U
Anticancer Res; 2016 Apr; 36(4):1943-8. PubMed ID: 27069184
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning.
Wright JL; Patil SM; Temple LK; Minsky BD; Saltz LB; Goodman KA
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1064-72. PubMed ID: 20350793
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.
Dell'Acqua V; Surgo A; Arculeo S; Zerella MA; Bagnardi V; Frassoni S; Zampino MG; Ravenda PS; Rotundo MS; Kraja F; Kobiela J; Spychalski P; Fodor C; Gerardi MA; Cattani F; Bazani A; Petz W; Glynne-Jones R; Orecchia R; Leonardi MC; Jereczek-Fossa BA
Int J Colorectal Dis; 2020 Apr; 35(4):685-694. PubMed ID: 32036405
[TBL] [Abstract][Full Text] [Related]
18. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA
Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience of SIB-IMRT in anal cancer and selective literature review.
Janssen S; Glanzmann C; Bauerfeind P; Stieb S; Studer G; Brown M; Riesterer O
Radiat Oncol; 2014 Sep; 9():199. PubMed ID: 25199879
[TBL] [Abstract][Full Text] [Related]
20. French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patients.
Vendrely V; Henriques de Figueiredo B; Rio E; Benech J; Belhomme S; Lisbona A; Frison E; Doussau A; Nomikossoff N; Mahé MA; Kantor G; Maire JP
Radiat Oncol; 2015 Aug; 10():170. PubMed ID: 26268888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
